Manuel Litchman's most recent trade in Mustang Bio Inc was a trade of 19 COMMON STOCK done at an average price of $0.7 . Disclosure was reported to the exchange on April 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mustang Bio Inc | Manuel Litchman | Director, President, CEO and Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.74 per share. | 24 Apr 2026 | 19 | 1,615 (0%) | 0% | 0.7 | 14 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President, CEO and Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.22 per share. | 24 Apr 2025 | 27 | 1,634 (0%) | 0% | 1.2 | 33 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.35 per share. | 31 May 2024 | 1,396 | 83,024 (0%) | 0% | 0.4 | 489 | Common Stock |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 5,000 | 111,079 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.21 per share. | 24 Apr 2022 | 1,572 | 79,420 (0%) | 0% | 4.2 | 6,618 | Common Stock |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.15 per share. | 24 Apr 2022 | 1,248 | 80,992 (0%) | 0% | 12.1 | 15,163 | Common Stock |
| Mustang Bio Inc | Manuel Litchman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2022 | 61,000 | 1,093,987 (2%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Mustang Bio Inc | Manuel Litchman | Director | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 18 Mar 2022 | 5,000 | 1,032,987 (2%) | 0% | 0.7 | 3,695 | COMMON STOCK, PAR VALUE $0.0001 |
| Mustang Bio Inc | Manuel Litchman | Director | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 18 Mar 2022 | 5,000 | 1,098,987 (2%) | 0% | 0.5 | 2,582 | COMMON STOCK, PAR VALUE $0.0001 |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 27 Oct 2021 | 65,000 | 1,027,987 (2%) | 0% | 2.2 | 145,600 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.58 per share. | 31 Aug 2021 | 2,746 | 962,987 (2%) | 0% | 2.6 | 7,085 | COMMON STOCK |
| Mustang Bio Inc | Manuel Litchman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 30 Jul 2021 | 86,206 | 960,241 (2%) | 0% | 2.9 | 250,859 | COMMON STOCK |